Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia (Q46691519)

24 December 2017

title

Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia (English)

1 reference

24 December 2017

0 references

1 reference

1

1 reference

24 December 2017

Ali Bazarbachi

object named as

A Bazarbachi

6

0 references

author name string

E Hamade

2

1 reference

24 December 2017

R Mahfouz

3

1 reference

24 December 2017

M S Nasrallah

4

1 reference

24 December 2017

H de Thé

5

1 reference

24 December 2017

publication date

20 March 2008

1 reference

24 December 2017

published in

Leukemia

1 reference

24 December 2017

volume

22

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

1125-1130

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.59

exact match

0 references

cites work

Cyclooxygenase expression is elevated in retinoic acid-differentiated U937 cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

How acute promyelocytic leukaemia revived arsenic

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Involvement of two Sp1 elements in basal endothelial prostaglandin H synthase-1 promoter activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.59

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.59

1 reference

24 December 2017

Dimensions Publication ID

1030224243

0 references

Fatcat ID

release_rng66cegfzfcjcptd44lhquk5u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rng66cegfzfcjcptd44lhquk5u

24 November 2022

mapped directly with Wikidata item

1 reference

24 December 2017